Cantor Fitzgerald Investment Advisors’s AbbVie ABBV Stock Holding History

Cantor Fitzgerald Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.23M	Sell	4,900 -8	-0.2%	-$1.72K	0.08%	125
2026 Q1	$1.07M	Buy	4,908 +608	+14%	+$135K	0.08%	125
2025 Q4	$983K	Hold	4,300	–	–	0.07%	133
2025 Q3	$996K	Hold	4,300	–	–	0.07%	138
2025 Q2	$798K	Hold	4,300	–	–	0.06%	142
2025 Q1	$901K	Hold	4,300	–	–	0.07%	133
2024 Q4	$764K	Sell	4,300 -28	-0.6%	-$5.15K	0.05%	138
2024 Q3	$855K	Buy	+4,328	New	+$808K	0.06%	136

Other funds holding ABBV

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Cantor Fitzgerald Investment Advisors's ABBV Position: Q2 2026 in Review

Cantor Fitzgerald Investment Advisors reduced its AbbVie (ABBV) stake by 0.16% in Q2 2026, selling an estimated $1.72K and leaving 4,900 shares worth $1.23M. The position accounts for 0.08% of the portfolio, ranked #125.

Cantor Fitzgerald Investment Advisors first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 2,508 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Cantor Fitzgerald Investment Advisors held 4,900 shares of AbbVie worth $1.23M as of Q2 2026.
Cantor Fitzgerald Investment Advisors sold 8 AbbVie shares in Q2 2026, an estimated $1.72K.
AbbVie made up 0.08% of Cantor Fitzgerald Investment Advisors's portfolio in Q2 2026, its #125 holding.
Cantor Fitzgerald Investment Advisors first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
2,508 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cantor Fitzgerald Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.